Delisting risk
BioNexus Gene Lab
Distributor of composite-industry chemicals with Malaysian genomic screening and an ASEAN cancer-testing license.
$1.52
After-hours close−0.01 (−0.65%)
At close$1.53(+2.00%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 0.01%232 sharesInsiders 37.63%909.7K sharesOther 62.36%1.51M shares
Shares outstanding 2.42M · Float 1.56M · 64.4% free float
Institutions13F, as of Mar 31, 2026
2 holders · 232 shares · 2 new positions · 2 increased · 0 reduced · 1 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| UBS Group AG | 231 | 0.01% | +231 | May 5, 2026 |
| Wells Fargo & Company/MN | 1 | 0.00% | +1new | Jul 8, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Tan Lee Su-Leng | 11.50% | 338.7K | 13D | Aug 14, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Fidelion Diagnostics Pte. Ltd. | other: Greater than 5% holder | 392.3K | 16.23% | Aug 7, 2026 |
| Lee Su-Leng Tan | director, 10 percent owner, officer: Chief Executive Officer | 338.7K | 14.01% | Aug 14, 2026 |
| Set Fui Chong | officer: Chief Financial Officer | 96.8K | 4.00% | Aug 14, 2026 |
| Abdul Hamid Muhammad Azrul Bin | director | 32.3K | 1.33% | Aug 14, 2026 |
| Chee Keong Yap | director | 32.3K | 1.33% | Aug 14, 2026 |
| Jook Yuen Low | director | 17.4K | 0.72% | Aug 14, 2026 |
2 people have not refiled in the last 18 months (1.73M shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.